Joseph Scheeren

This profile gathers the share dealings of Joseph Scheeren in Vaccitech plc, where the filings describe the role as senior executive. Over a trading history stretching from 4 May 2021 to 9 September 2026, the count stands at 4 filings.

Every open-market trade on record is a purchase: 3 purchases worth €111k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

The median purchase comes to €42k. Of 3 purchases, 2 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 9 September 2026: a transaction, in Vaccitech plc. The last insider purchase was made public on 28 June 2023, 1,215 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.